Cargando…
Untargeted Plasma Metabolomic Profiling in Patients with Major Depressive Disorder Using Ultra-High Performance Liquid Chromatography Coupled with Mass Spectrometry
Major depressive disorder (MDD) is a neuropsychiatric illness with an increasing incidence and a shortfall of efficient diagnostic tools. Interview-based diagnostic tools and clinical examination often lead to misdiagnosis and inefficient systematic treatment selection. Diagnostic and treatment moni...
Autores principales: | Homorogan, Claudia, Nitusca, Diana, Enatescu, Virgil, Schubart, Philip, Moraru, Corina, Socaciu, Carmen, Marian, Catalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306682/ https://www.ncbi.nlm.nih.gov/pubmed/34357360 http://dx.doi.org/10.3390/metabo11070466 |
Ejemplares similares
-
Comparative analysis of plasma metabolomics markers in patients with major depressive disorder and healthy controls
por: Homorogan, C., et al.
Publicado: (2022) -
Metabolomic Analysis of Plasma from Breast Cancer Patients Using Ultra-High-Performance Liquid Chromatography Coupled with Mass Spectrometry: An Untargeted Study
por: Da Cunha, Patricia A., et al.
Publicado: (2022) -
Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators
por: Homorogan, Claudia, et al.
Publicado: (2021) -
Distribution of microRNAs associated with major depressive disorder among blood compartments
por: Homorogan, Claudia, et al.
Publicado: (2021) -
Untargeted Metabolomics by Ultra-High-Performance Liquid Chromatography Coupled with Electrospray Ionization-Quadrupole-Time of Flight-Mass Spectrometry Analysis Identifies a Specific Metabolomic Profile in Patients with Early Chronic Kidney Disease
por: Glavan, Mihaela-Roxana, et al.
Publicado: (2023)